Joseph N Jarvis

10.4k total citations · 1 hit paper
133 papers, 6.1k citations indexed

About

Joseph N Jarvis is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joseph N Jarvis has authored 133 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Epidemiology, 98 papers in Infectious Diseases and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joseph N Jarvis's work include Fungal Infections and Studies (87 papers), Antifungal resistance and susceptibility (74 papers) and Nail Diseases and Treatments (37 papers). Joseph N Jarvis is often cited by papers focused on Fungal Infections and Studies (87 papers), Antifungal resistance and susceptibility (74 papers) and Nail Diseases and Treatments (37 papers). Joseph N Jarvis collaborates with scholars based in United Kingdom, Botswana and United States. Joseph N Jarvis's co-authors include Thomas S. Harrison, Angela Loyse, Graeme Meintjes, Nelesh P. Govender, Tom Chiller, Radha Rajasingham, Benjamin J. Park, David R. Boulware, David W. Denning and Rachel M. Smith and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Joseph N Jarvis

117 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

2017 1.3k citations Joseph N Jarvis, Nelesh P. Govender et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph N Jarvis United Kingdom	38	5.0k	4.5k	518	384	303	133	6.1k
Radha Rajasingham United States	25	3.0k 0.6×	2.8k 0.6×	164 0.3×	275 0.7×	225 0.7×	74	3.6k
Sarah Kidd Australia	35	3.0k 0.6×	2.9k 0.6×	246 0.5×	554 1.4×	575 1.9×	125	4.6k
David R. Boulware United States	52	6.9k 1.4×	6.8k 1.5×	731 1.4×	522 1.4×	718 2.4×	294	10.3k
Margaret K. Hostetter United States	34	1.3k 0.3×	1.5k 0.3×	415 0.8×	215 0.6×	428 1.4×	108	4.0k
Rosemary A. Barnes United Kingdom	34	2.3k 0.5×	2.4k 0.5×	60 0.1×	129 0.3×	70 0.2×	106	3.4k
David W. Kimberlin United States	41	5.8k 1.2×	2.6k 0.6×	597 1.2×	63 0.2×	259 0.9×	153	7.1k
Esther Segal Israel	27	1.1k 0.2×	1.4k 0.3×	91 0.2×	258 0.7×	263 0.9×	129	2.5k
Roberta L. DeBiasi United States	28	1.3k 0.3×	1.8k 0.4×	1.2k 2.2×	42 0.1×	187 0.6×	87	3.5k
Christopher C. Kibbler United Kingdom	26	1.4k 0.3×	1.7k 0.4×	137 0.3×	190 0.5×	88 0.3×	54	2.8k
Wenbo Xu China	40	2.3k 0.5×	3.3k 0.7×	209 0.4×	118 0.3×	64 0.2×	259	6.0k

Countries citing papers authored by Joseph N Jarvis

Since Specialization

Citations

This map shows the geographic impact of Joseph N Jarvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph N Jarvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph N Jarvis more than expected).

Fields of papers citing papers by Joseph N Jarvis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph N Jarvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph N Jarvis. The network helps show where Joseph N Jarvis may publish in the future.

Co-authorship network of co-authors of Joseph N Jarvis

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph N Jarvis. A scholar is included among the top collaborators of Joseph N Jarvis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph N Jarvis. Joseph N Jarvis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Govender, Nelesh P., et al.. (2025). Diagnosis of cryptococcal meningitis in people living with HIV in low-income countries: barriers and strategies. Expert Review of Anti-infective Therapy. 23(10). 893–905.

Jarvis, Joseph N, Peter Ehrenkranz, David S. Lawrence, et al.. (2025). Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS. The Lancet HIV. 13(3). e207–e212.

Jarvis, Joseph N, et al.. (2025). Universal “Test and Treat” for HIV Had Little Effect on Outcomes, but Missed Clinic Visits Threaten Success of Botswana’s National Antiretroviral Treatment Program. AIDS Patient Care and STDs. 39(6). 215–223.

Ueno, Akitoshi, Ross Murtagh, Seyed Alireza Mortazavi, et al.. (2025). Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta‐analysis. HIV Medicine. 27(1). 120–135.

Kagimu, Enock, Nathan C. Bahr, Michael Okirwoth, et al.. (2024). Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study. Clinical Infectious Diseases. 80(2). 417–424. 1 indexed citations

Milburn, James, et al.. (2024). The diagnosis of central nervous system infections in resource-limited settings and the use of novel and molecular diagnostic platforms to improve diagnosis. Expert Review of Molecular Diagnostics. 24(3). 219–230. 1 indexed citations

Stott, Katharine E., Jennifer L. Tenor, Dena L. Toffaletti, et al.. (2024). Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis. mBio. 15(10). e0159224–e0159224. 1 indexed citations

Ellis, Jayne, Ananta Bangdiwala, Caleb P Skipper, et al.. (2023). Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV. Open Forum Infectious Diseases. 10(9). ofad449–ofad449. 3 indexed citations

Moyo, Sikhulile, Kwana Lechiile, Tshepo Leeme, et al.. (2022). Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana. Biomedicines. 10(6). 1399–1399. 3 indexed citations

10.

Lawrence, David S., Agnes Ssali, Thomas S. Harrison, et al.. (2022). The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda. PLoS neglected tropical diseases. 16(10). e0010825–e0010825. 6 indexed citations

11.

Lakoh, Sulaiman, Joseph N Jarvis, Bright Ocansey, et al.. (2022). Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey. The Lancet Infectious Diseases. 23(5). 598–608. 30 indexed citations

12.

Lawrence, David S., Agnes Ssali, Thomas S. Harrison, et al.. (2022). Decision making in a clinical trial for a life-threatening illness: Therapeutic expectation, not misconception. Social Science & Medicine. 305. 115082–115082. 6 indexed citations

13.

Moyo, Sikhulile, Kwana Lechiile, Dorcas Maruapula, et al.. (2020). Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana. Medicine. 99(41). e22606–e22606. 4 indexed citations

14.

Kannambath, Shichina, Joseph N Jarvis, Rachel Wake, et al.. (2020). Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans. Open Forum Infectious Diseases. 7(11). ofaa489–ofaa489. 13 indexed citations

15.

Moyo, Sikhulile, Kwana Lechiile, Tshepo Leeme, et al.. (2020). HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana. Viruses. 12(12). 1404–1404. 2 indexed citations

16.

Park, Yoon‐Dong, Joseph N Jarvis, Guowu Hu, et al.. (2018). Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. mBio. 9(6). 4 indexed citations

17.

Rhodes, Johanna, Mathew A. Beale, Mathieu Vanhove, et al.. (2017). A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection. G3 Genes Genomes Genetics. 7(4). 1165–1176. 66 indexed citations

18.

Jarvis, Joseph N, Tihana Bicanic, Angela Loyse, et al.. (2014). Very Low Levels of 25-Hydroxyvitamin D Are Not Associated With Immunologic Changes or Clinical Outcome in South African Patients With HIV-Associated Cryptococcal Meningitis. Clinical Infectious Diseases. 59(4). 493–500. 12 indexed citations

19.

Jarvis, Joseph N, Joseph P. Casazza, Graeme Meintjes, et al.. (2013). The Phenotype of the Cryptococcus-Specific CD4+ Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis. The Journal of Infectious Diseases. 207(12). 1817–1828. 105 indexed citations

20.

Jarvis, Joseph N, et al.. (2007). Treatment of HIV-associated cryptococcal meningitis in South Africa: The case for amphotericin B over conventional dose fluconazole for initial therapy. Southern African Journal of HIV Medicine. 8(3). 36–39. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact